Harrow Health Inc.

NASDAQ: HROW · Real-Time Price · USD
40.06
3.56 (9.75%)
At close: Aug 14, 2025, 3:59 PM
40.50
1.09%
Pre-market: Aug 15, 2025, 07:06 AM EDT

Harrow Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
199.61M 130.19M 88.59M 72.48M
Cost of Revenue
49.24M 39.64M 25.38M 18.21M
Gross Profit
150.37M 90.55M 63.21M 54.26M
Operating Income
8.82M 431K 1.92M 1.61M
Interest Income
n/a n/a n/a 5.44M
Pretax Income
-17.32M -23.71M -14.01M -17.87M
Net Income
-17.48M -24.41M -14.09M -18.01M
Selling & General & Admin
129.06M 83.09M 58.24M 41.31M
Research & Development
12.23M 6.65M 3.05M 11.08M
Other Expenses
722K 380K n/a n/a
Operating Expenses
142.02M 90.12M 61.29M 52.4M
Interest Expense
22.79M 21.32M 7.24M 5.44M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
190.79M 129.76M 86.68M 70.61M
Income Tax Expense
161K 701K 75K 133K
Shares Outstanding (Basic)
35.65M 32.62M 27.46M 26.76M
Shares Outstanding (Diluted)
35.65M 32.62M 27.46M 26.76M
EPS (Basic)
-0.49 -0.75 -0.51 -0.69
EPS (Diluted)
-0.49 -0.75 -0.51 -0.69
EBITDA
19.28M 9.72M -3.1M 4.26M
EBIT
4.74M -2.62M -6.77M 1.86M
Depreciation & Amortization
14.54M 12.34M 3.67M 2.4M